Reframing Expectations About Aging - Physical Activity and Inclusive Reappraisal
NCT07113860, Not applicable, Recruiting, University of Barcelona
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Reframing Expectations About Aging - Physical Activity and Inclusive Reappraisal | ClinicalTrials.gov |
| NCT number | NCT07113860 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 342 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University of Barcelona | ClinicalTrials.gov |
| Conditions | Self-perceptions of Aging, Physical Activity | ClinicalTrials.gov |
| Interventions | Views on Aging Intervention, Projecte Moviment | ClinicalTrials.gov |
| First posted | 2025-08-11 | ClinicalTrials.gov |
| Last updated | 2025-08-19 | ClinicalTrials.gov |
Registered outcomes 17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Awareness of Age-Related Change | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | This 10-item measure assesses self-perceptions of aging. More specifically, it assesses perceived age-related gains and losses. Each of the items of the perceived age-related gains and losses subscales represents one of the five AARC behavioral domains that are health and physical functioning; cognitive functioning; interpersonal relations; social-cognitive and social-emotional functioning; and lifestyle and engagement. Respondents rate how much each item applies to them on a five-point Likert scale (1= not at all; 2= a little bit; 3= moderately; 4= quite a bit; 5= very much). Higher scores indicate higher perceived age-related gains and losses, respectively (range: 5-25). | ClinicalTrials.gov |
| Primary | Felt Age | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | This measure assesses self-perceptions of aging. Felt age (FA) will be assessed with a single-item question asking participants to write the age (in years) that they feel most of the time. A proportional discrepancy score will be calculated by subtracting the participants' chronological age from their felt age, and by dividing this difference score by participants' chronological age. A positive value indicates an older felt age, whereas a negative value indicates a younger felt age. Typically, in western countries the majority of older individuals feel between 13% and 18% younger than their age, and a younger felt age is used as indicator of more positive self-perceptions of aging. | ClinicalTrials.gov |
| Primary | Subjective Nearness to Death | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | This measure assesses self-perceptions of aging. Subjective Nearness to Death will be assessed with the one-item question: I have a feeling that my life is approaching its end. Answer options range from 1 (not at all) to 5 (very much). | ClinicalTrials.gov |
| Primary | International Physical Activity Questionnaire | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | This measure assesses self-reported physical activity. Participants are asked to refer to the past seven days and to report how much time they spent sitting during a day; how many days they walked for at least ten minutes at a time; how many days they did moderate physical activities like gardening, cleaning, and bicycling; and how many days they did vigorous physical activities like heavy lifting, heavier garden or construction work, and aerobics. Separate scores can be obtained for walking, moderate intensity physical activities, and vigorous physical activities as follows: (1) Walking metabolic equivalent of task (MET)-minutes/week = 3.3 \* walking minutes \* walking days. (2) Moderate MET-minutes/week = 4.0 \* moderate-intensity activity minutes \* moderate days. (3) Vigorous MET-minutes/week = 8.0 \* vigorous-intensity activity minutes \* vigorous-intensity days. The International Physical Activity Questionnaire total score derives from the sum of the scores for walking, moderate-inten | ClinicalTrials.gov |
| Primary | Saltin-Grimby Physical Activity Level Scale | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | This measure assesses self-reported physical activity.The Saltin-Grimby Physical Activity Level Scale consists in a single-item question asking participants to report on average how much they moved during their leisure time. At baseline participants will be asked to answer thinking about the past 12 months whereas at follow-ups they will be asked to think about the past three months. To answer, participants can choose from four categories: 1= physically inactive, 2= some light physical activity, 3= regular physical activity and training, and 4= regular hard physical training for competitive sports. | ClinicalTrials.gov |
| Secondary | World Health Organization - Ageism Scale | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | Experienced ageism will be assessed with 15-items covering self-directed ageism: self-stereotypes (two items), self-prejudice (one item), self-discrimination (two items; interpersonal ageism: interpersonal stereotypes (two items), interpersonal prejudices (two items), interpersonal discrimination (three items) and institutional ageism: institutional discrimination (three items). Answer options for all items are 1= strongly disagree; 2= disagree; 3= neither agree nor disagree; 4= agree; 5= strongly agree. The total score is obtained from the sum of items scores. Higher scores indicate greater ageism. Other directed-ageism will be assessed with 23 additional questions developed by the Word Health Organization. Answer options for all items are 1= totally agree; 2= agree; 3= neither agree nor disagree; 4= disagree; 5= strongly disagree. The total score is obtained from the sum of items scores. Higher scores indicate less other-directed ageism. | ClinicalTrials.gov |
| Secondary | Subjective Views of Couple's Joint Aging | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | The 14-item Subjective Views of Couple's Joint Aging (SVoCJA) scale will be used to assess positive and negative subjective views of couple's joint aging. Seven items capture positive subjective views of couple's joint aging and a sample item is the thought that our time together is limited will make us want to love each other more. The remaining seven items capture negative subjective views of couple's joint aging and a sample item is Dealing with health issues will take a heavy toll on our relationship. Each item is answered on a five-point Likert scale: 1= strongly disagree; 2= slightly disagree; 3= neither agree nor disagree; 4= slightly agree; 5= very much agree. Subscales scores are obtained by summing up the scores of their respective items. In the validation sample, Cronbach's alpha coefficients were 0.77 for positive and 0.78 for negative subjective views of couples' joint aging. | ClinicalTrials.gov |
| Secondary | Patient Health Questionnaire - 4 | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | This measure assesses core symptoms of depression and anxiety over the past two weeks. A sample item is Over the last two weeks, how often have you felt little interest or pleasure in doing things? Answer options are on a four-point Likert scale: 1= not at all; 2= several days; 3= more than half the days; 4= nearly every day. The total score is obtained from the sum of items scores. Higher total scores (range: 4-16) indicate more non-specific mood problems. Cronbach's alpha was above 0.80 for both depression and anxiety subscales in the validation sample, indicating good internal reliability. | ClinicalTrials.gov |
| Secondary | Body Mass Index | Baseline, post-intervention (12 weeks after baseline), and three- and six-months follow-ups (post-intervention) | Participants will self-report their height in cm and weight in kg. | ClinicalTrials.gov |
| Secondary | Grip Strength | Baseline, post-intervention (12 weeks after baseline), and six-months follow-ups (post-intervention) | This is an indicator of physical fitness | ClinicalTrials.gov |
| Secondary | Senior Fitness Test | Baseline, post-intervention (12 weeks after baseline), and six-months follow-ups (post-intervention) | It comprises 6 tests. The Chair Stand Test asks participants to repeatedly stand up from and sit down on a chair for 30 sec. The number of stands is recorded. The Biceps Curl Test asks participants to repeatedly lift a 2.27 kg weight for women or an 3.63 kg weight for men for 30 sec. The number of lifts is recorded. The 6-Minute Walk Test asks participants to walk for 6 min on a straight line. The meters walked are recorded. The Chair Sit and Reach Test asks participants to reach forward toward the toes by bending at the hip while being seated. The distance is recorded. The Back Scratch Test asks participants to start from standing position, place one hand behind the head and back over the shoulder and reach as far as possible down the middle of the back and place the other arm behind their back and reach up attempting to touch or overlap the middle fingers of both hands. In the 2.45-m Up-and-Go Test participants stand up from a chair and walk around a cone and to return to the chair. | ClinicalTrials.gov |
| Secondary | Trial Making Text A and B | Baseline, post-intervention (12 weeks after baseline), and six-months follow-ups (post-intervention) | This task assesses cognitive flexibility. Trail Making Test-A requires participants to draw lines sequentially connecting 25 encircled numbers distributed on a sheet of paper. Task requirements are similar for Trail Making Test-B except the participant must alternate between numbers and letters (e.g., 1, A, 2, B, 3, C, etc.). For both Trail Making Test A and B the total score is the amount of time required to complete the task. | ClinicalTrials.gov |
| Secondary | Digit Span Forward and Backward | Baseline, post-intervention (12 weeks after baseline), and six-months follow-ups (post-intervention) | This task assesses working memory. In the Digit Span Backward participants are asked to repeat digits backward (14 number sequences that range from five to eight digits in length). Each correctly recalled sequence is scored as one point (possible total score range: 0-14). Higher scores indicate greater working memory. In the Digit Span Forward (96) participants are asked to repeat digits forward (14 number sequences ranging from three to nine digits). Each correctly recalled sequence is scored as one point (possible total score range: 0-14). Higher scores indicate greater short-term memory. | ClinicalTrials.gov |
| Secondary | PMR Phonological Verbal Fluency Test | Baseline, post-intervention (12 weeks after baseline), and six-months follow-ups (post-intervention) | This task assesses working memory. In the PMR Phonological Verbal Fluency Test participants are asked to generate within 60 seconds as many words as possible that start with the letters P, M, and R. For each letter the number of correct words is registered, excluding intrusions and perseverations. This task also assesses executive functions in addition to working memory. | ClinicalTrials.gov |
| Secondary | Animal Naming Fluency Test | Baseline, post-intervention (12 weeks after baseline), and six-months follow-ups (post-intervention) | This task assesses working memory. In the Animal Naming Fluency Test participants are asked to generate as many animal names as possible within 60 seconds. This task also assesses executive functions in addition to working memory. The number of correct words is registered, excluding intrusions and perseverations. | ClinicalTrials.gov |
| Secondary | Weist circumference | Baseline, three-months follow-up, and 6-months follow-up. | Waist circumference will be assessed by the researcher during the baseline, post-intervention, and six-month in person follow-up assessments using a flexible measuring tape. The measure will be taken at midpoint between the lower margin of the last palpable rib and the top of the hip bone. | ClinicalTrials.gov |
| Secondary | Stroop Color-Word Test | Baseline, three-month follow-up and six-month follow-up. In this test, participants are shown a list of color words, such as "red," "blue," "green", printed in different-colored inks. The ink color may match the word (i.e., congruent condition) or differ | This task assesses inhibition. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 42135676 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Secondary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)